XDNA
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
XDNA
Delisted
XDNA was delisted on the 30th of November, 2023.
2 hedge funds and large institutions have $281K invested in Strategic Trust Kelly CRISPR & Gene Editing Technology ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2K |
Top Sellers
| 1 |
Jane Street
New York
|
-$486K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $279K | -$486K | -47,691 | -64% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$2K | +151 | New |
|